Jim has spent over 40 years in the field of drug discovery and development, working at companies of varying sizes, including Johnson & Johnson, SmithKline Beecham, GlaxoSmithKline, Array BioPharma, Arvinas, FORMA, Frontier Medicines, Day One, and OnKure. While working for these companies, he has gained extensive experience building and leading teams from target validation, early drug discovery, preclinical, through to clinical development and proof of concept. At Array, Jim was VP of Discovery and Translational Medicine and worked with the teams to build an impressive pipeline, moving over 16 drugs into development. At Arvinas, Jim was Chief Scientific Officer, helping the new company build and validate novel PROTAC degrader technology, advancing this technology to discover new drugs.  At Frontier Medicines, Jim has served as Head of Degrader Technologies. Jim continues to use his experience to help companies become established, grow, and create novel therapies for patients.